These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8658058)

  • 21. Changes in serum specific IgG4 and IgG4/ IgE ratio in mite-sensitized Taiwanese children with allergic rhinitis receiving short-term sublingual-swallow immunotherapy: a multicenter, randomized, placebo-controlled trial.
    Tseng SH; Fu LS; Nong BR; Weng JD; Shyur SD
    Asian Pac J Allergy Immunol; 2008; 26(2-3):105-12. PubMed ID: 19054928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy affects the seasonal increase in specific IgE and interleukin-4 in serum of patients with seasonal allergic rhinitis.
    Ohashi Y; Nakai Y; Kakinoki Y; Ohno Y; Tanaka A; Masamoto T; Sakamoto H; Washio Y; Kato A
    Scand J Immunol; 1997 Jul; 46(1):67-77. PubMed ID: 9246210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of allergen specific immunotherapy (IT) on natural killer cell activity (NK), IgE, IFN-gamma levels and clinical response in patients with allergic rhinitis and asthma.
    Sin B; Misirligil Z; Aybay C; Gürbüz L; Imir T
    J Investig Allergol Clin Immunol; 1996; 6(6):341-7. PubMed ID: 9015776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy in allergic rhinitis.
    Palma-Carlos AG; Spinola-Santos A; Ferreira MB; Santos MC; Palma-Carlos ML
    Allerg Immunol (Paris); 2001 Oct; 33(8):323-6. PubMed ID: 11763723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical efficacy and immunological changes in children with allergic rhinitis receiving specific immunotherapy with Dermatophagoides pteronyssinus].
    Wang CS; Zhang W; Wang XD; Xi L; Ouyang YH; Zhao Y; Wang Y; Zhang L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jan; 46(1):36-9. PubMed ID: 21429334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of specific immunotherapy on the regulation of Th1/Th2 cell ratio of the patients with allergic rhinitis in serum].
    Xiao C; Li H; Li H; Cheng Z; Qin J; Zhou W; He Q; Xu X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Oct; 24(20):924-7. PubMed ID: 21171297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses.
    McHugh SM; Lavelle B; Kemeny DM; Patel S; Ewan PW
    J Allergy Clin Immunol; 1990 Oct; 86(4 Pt 1):521-31. PubMed ID: 1699985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals.
    Secrist H; Chelen CJ; Wen Y; Marshall JD; Umetsu DT
    J Exp Med; 1993 Dec; 178(6):2123-30. PubMed ID: 7902409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term efficacy of nasal immunotherapy.
    Palma-Carlos AG; Santos AS; Pregal A
    Allerg Immunol (Paris); 1998 Jan; 30(1):14-7. PubMed ID: 9503098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for adverse systemic reactions occurring during immunotherapy with standardized Dermatophagoides farinae extracts.
    Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Ohno Y; Yamada K; Nasako Y
    Acta Otolaryngol Suppl; 1998; 538():113-7. PubMed ID: 9879410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes of house dust mite-specific IgE, IgG and IgG subclass antibodies during immunotherapy in patients with perennial rhinitis.
    Nakagawa T; Kozeki H; Katagiri J; Fujita Y; Yamashita N; Miyamoto T; Skvaril F
    Int Arch Allergy Appl Immunol; 1987; 82(1):95-9. PubMed ID: 3804457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of serum IgE antibodies to the Staphylococcus aureus enterotoxins (SAE, SEB, SEC, SED, TSST-1) in patients with persistent allergic rhinitis.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Mar; 133(3):261-6. PubMed ID: 14976395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humoral response to subcutaneous, oral, and nasal immunotherapy for allergic rhinitis due to Dermatophagoides pteronyssinus.
    Piazza I; Bizzaro N
    Ann Allergy; 1993 Nov; 71(5):461-9. PubMed ID: 7755664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term efficacy of Dermatophagoides pteronyssinus immunotherapy in patients with allergic rhinitis: a 3-year prospective study].
    Wang CS; Wang XD; Zhang W; She WY; Xi L; Ouyang YH; Zhao Y; Zhang L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 47(10):804-8. PubMed ID: 23302159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of the frequency and function of IL-10-secreting type I T regulatory cells after 1 year of cluster allergen-specific immunotherapy.
    Lou W; Wang C; Wang Y; Han D; Zhang L
    Int Arch Allergy Immunol; 2012; 159(4):391-8. PubMed ID: 22846686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of serum specific IgE and skin prick test in allergic rhinitis patients sensitive to dust mite].
    Wei X; Fu Z; Lin X; Li J; Deng H; Li H; Wang X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Apr; 27(8):404-6. PubMed ID: 23858721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum IFN-gamma and IL-10 levels before and after specific immunotherapy in patients with allergic rhinitis.
    Keskin G; Inal A; Ali Sari R; Sengül A; Sahin M; Turgay M; Kinikli G
    Allergol Immunopathol (Madr); 1999; 27(5):261-4. PubMed ID: 10568876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The herbal medicine shoseiryu-to inhibits allergen-induced synthesis of tumour necrosis factor alpha by peripheral blood mononuclear cells in patients with perennial allergic rhinitis.
    Tanaka A; Ohashi Y; Kakinoki Y; Washio Y; Yamada K; Nakai Y; Nakano T; Nakai Y; Ohmoto Y
    Acta Otolaryngol Suppl; 1998; 538():118-25. PubMed ID: 9879411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum level of soluble interleukin-2 receptor in patients with seasonal allergic rhinitis.
    Ohashi Y; Tanaka A; Kakinoki Y; Ohno Y; Sakamoto H; Kato A; Masamoto T; Wahio Y; Nakai Y
    Scand J Immunol; 1997 Mar; 45(3):315-21. PubMed ID: 9122623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical study of curing patients with perennial allergic rhinitis by qumin tongbi nasal spraying agent].
    Chen XX; Fu JX; Huang J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 May; 31(5):643-6. PubMed ID: 21812266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.